AstraZeneca’s prevention treatment, Evusheld, may be a great option for high-risk patients that do not qualify for a COVID-19. Based on recent studies, the results are very promising.
Defined as monoclonal antibody therapy, this treatment infuses your body with antibodies designed to resist infection from strains of COVID-19.
Evusheld consists of two shots injected, one right after the other. It’s designed to be effective for up to 6 months and can be re-administered once that time has passed.
The results have been very promising. Based on their studies, Evusheld can reduce the risk of infection by 77% in high-risk patients, which is significant.
Who should get Evusheld treatment
It’s important to note that Evusheld is not a replacement for a vaccine. This was meant for individuals that are considered “high risk,” which includes:
- People with compromised immune systems
- Individuals allergic to the vaccine
- Patients taking immuno-suppressants
Best ways to get an Evusheld treatment
There are a couple of options when trying to receive this treatment. Hawaii residents can visit a clinic or urgent care facility to get their shots.
Another option is to receive in-home Evusheld treatment where a medical professional will come to you and administer the treatment. Many people in Hawaii opt for this option as it provides greater peace of mind.
With promising results, Evusheld is a great option for high-risk patients seeking greater protection against COVID.